Header cover image

Australian (ASX) Biotech Industry Analysis

UpdatedMay 30, 2023
DataAggregated Company Financials
Companies40
  • 7D0.09%
  • 3M4.2%
  • 1Y12.1%
  • YTD9.2%

The Biotech industry has been flat over the last week, but Telix Pharmaceuticals has lost 3.2%. The past year has been better, since the industry has gained 12% in that time. As for the next few years, earnings are expected to grow by 20% per annum.

Industry Valuation and Performance

Has the Australian Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 30 May 2023AU$157.4bAU$18.4bAU$2.4b40.4x66x8.6x
Thu, 27 Apr 2023AU$156.3bAU$18.2bAU$2.3b41.8x66.6x8.6x
Sat, 25 Mar 2023AU$146.9bAU$18.1bAU$2.3b39.3x62.7x8.1x
Mon, 20 Feb 2023AU$151.9bAU$17.3bAU$2.3b51.3x66.5x8.8x
Wed, 18 Jan 2023AU$148.4bAU$15.5bAU$2.5b52.2x60.5x9.6x
Fri, 16 Dec 2022AU$151.7bAU$15.9bAU$2.5b46.9x59.9x9.5x
Sun, 13 Nov 2022AU$149.4bAU$16.1bAU$2.6b45.4x58.5x9.3x
Tue, 11 Oct 2022AU$144.3bAU$16.8bAU$2.7b40.7x53.4x8.6x
Thu, 08 Sep 2022AU$149.5bAU$15.8bAU$2.5b44.6x59.4x9.5x
Sat, 06 Aug 2022AU$151.3bAU$15.5bAU$2.8b41.6x54.2x9.8x
Mon, 04 Jul 2022AU$135.9bAU$15.9bAU$2.9b34.5x47.3x8.6x
Wed, 01 Jun 2022AU$137.8bAU$15.0bAU$2.7b36.5x51.2x9.2x
Fri, 29 Apr 2022AU$136.3bAU$15.1bAU$2.8b36.3x49.4x9x
Sun, 27 Mar 2022AU$135.1bAU$14.3bAU$2.6b39.4x52.1x9.4x
Tue, 22 Feb 2022AU$136.0bAU$15.0bAU$2.7b39.2x50.2x9.1x
Thu, 20 Jan 2022AU$140.5bAU$14.6bAU$2.8b39.2x50.6x9.6x
Sat, 18 Dec 2021AU$142.1bAU$14.6bAU$2.8b39.5x51.3x9.8x
Mon, 15 Nov 2021AU$153.3bAU$14.3bAU$2.7b43.2x56.7x10.7x
Wed, 13 Oct 2021AU$145.1bAU$14.2bAU$2.7b41.4x54.1x10.2x
Fri, 10 Sep 2021AU$150.1bAU$14.0bAU$2.6b43.5x57.2x10.7x
Sun, 08 Aug 2021AU$146.2bAU$14.0bAU$2.6b42.8x55.7x10.5x
Sat, 01 May 2021AU$132.5bAU$13.5bAU$2.8b37.3x46.8x9.8x
Tue, 02 Feb 2021AU$132.3bAU$13.1bAU$3.0b35.8x44.2x10.1x
Fri, 06 Nov 2020AU$138.5bAU$13.5bAU$2.9b31.2x48.1x10.2x
Mon, 10 Aug 2020AU$130.3bAU$13.5bAU$2.7b40.3x48.9x9.7x
Price to Earnings Ratio

44.6x


Total Market Cap: AU$132.9bTotal Earnings: AU$3.0bTotal Revenue: AU$14.9bTotal Market Cap vs Earnings and Revenue0%0%0%
Australian Biotech Industry Price to Earnings3Y Average 53x202120222023
Current Industry PE
  • Investors are optimistic on the Australian Biotechnology industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 66.0x which is higher than its 3-year average PE of 53.0x.
  • The 3-year average PS ratio of 9.7x is higher than the industry's current PS ratio of 8.6x.
Past Earnings Growth
  • The earnings for companies in the Biotechnology industry have declined 7.1% per year over the last three years.
  • Meanwhile revenues for these companies have grown 7.1% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Comparison

How does Australian Biotech compare with similar industries?

AU Market-0.72%
Healthcare-0.40%
Biotech0.088%
Biotech0.088%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
ARX Aroa BiosurgeryAU$1.008.7%
+AU$27.4m
27.4%PS7.2x
PAB PatrysAU$0.01220.0%
+AU$4.1m
-46.7%PS7x
CYP Cynata TherapeuticsAU$0.1411.5%
+AU$2.7m
-63.7%PS10x
NSB NeuroScientific BiopharmaceuticalsAU$0.1111.1%
+AU$1.6m
-54.2%PS13.6x
TRP Tissue RepairAU$0.2810.0%
+AU$1.5m
-1.8%PS96.7x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

MSB

AU$1.08

Mesoblast

7D

-2.3%

1Y

9.1%

IMM

AU$0.30

Immutep

7D

-7.6%

1Y

-27.4%

ARX

AU$1.00

Aroa Biosurgery

7D

8.7%

1Y

27.4%

IMU

AU$0.11

Imugene

7D

-8.3%

1Y

-43.6%

RAC

AU$1.51

Race Oncology

7D

-6.2%

1Y

-29.1%

TLX

AU$11.11

Telix Pharmaceuticals

7D

-6.2%

1Y

138.4%

DXB

AU$0.075

Dimerix

7D

4.2%

1Y

-48.3%

OCC

AU$0.35

Orthocell

7D

1.4%

1Y

-2.7%

BDX

AU$0.093

BCAL Diagnostics

7D

3.3%

1Y

-3.1%

NSB

AU$0.11

NeuroScientific Biopharmaceuticals

7D

11.1%

1Y

-54.2%

TRP

AU$0.28

Tissue Repair

7D

10.0%

1Y

-1.8%